Announcing IndieBio SF’s Next Wave – VC-Founder Meetings (June 17 to 21) Learn More

Unlocked Labs

Optimized Probiotics with Measurable Outcomes


Christoph Geisler


James Francis

Chief Operating Officer

Company details

Unlocked is developing probiotics with enhanced abilities to take up and break down compounds in the GI tract – thereby safely bringing down levels throughout the human body. Our platform approach is to activate dormant probiotic genes, enabling Unlocked to target specific compounds that are the root causes of serious chronic health conditions. We’re cutting out the onerous FDA drug approval process by exploiting the GRAS status, medical food, route. This allows us to perfect our product market fit before starting the clinical trials that will provide the scientific backing consumers are looking for.

Get In Touch with Unlocked Labs

Please tell us a little bit about yourself and why you'd like to get connected. Unlocked Labs + SOSV will follow up with you via email.


No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.